These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29388750)

  • 1. High proportion of patients with bleeding of unknown cause in persons with a mild-to-moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB).
    Gebhart J; Hofer S; Panzer S; Quehenberger P; Sunder-Plassmann R; Hoermann G; Eigenbauer E; Haslacher H; Kepa S; Kyrle PA; Eichinger S; Knöbl P; Eischer L; Mannhalter C; Ay C; Pabinger I
    Haemophilia; 2018 May; 24(3):405-413. PubMed ID: 29388750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease.
    de Wee EM; Sanders YV; Mauser-Bunschoten EP; van der Bom JG; Degenaar-Dujardin ME; Eikenboom J; de Goede-Bolder A; Laros-van Gorkom BA; Meijer K; Hamulyák K; Nijziel MR; Fijnvandraat K; Leebeek FW;
    Thromb Haemost; 2012 Oct; 108(4):683-92. PubMed ID: 22918553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease.
    Siboni SM; Biguzzi E; Caiani V; Mistretta C; Bucciarelli P; Peyvandi F
    Haemophilia; 2016 Jul; 22(4):564-9. PubMed ID: 26843468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion.
    Mehic D; Gebhart J; Pabinger I
    Hamostaseologie; 2024 Aug; 44(4):287-297. PubMed ID: 38412996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of Von Willebrand disease and inherited platelet function disorders amongst Indian bleeders.
    Gupta PK; Charan VD; Saxena R
    Ann Hematol; 2007 Jun; 86(6):403-7. PubMed ID: 17375300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Willebrand's disease: case report and review of literature.
    Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
    Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
    Castaman G; Federici AB; Rodeghiero F; Mannucci PM
    Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal recessive inherited bleeding disorders in Pakistan: a cross-sectional study from selected regions.
    Naz A; Jamal MY; Amanat S; Din Ujjan I; Najmuddin A; Patel H; Raziq F; Ahmed N; Imran A; Shamsi TS
    Orphanet J Rare Dis; 2017 Apr; 12(1):66. PubMed ID: 28388959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic challenges of inherited mild bleeding disorders: a bait for poorly explored clinical and basic research.
    Mezzano D; Quiroga T
    J Thromb Haemost; 2019 Feb; 17(2):257-270. PubMed ID: 30562407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological determinants of bleeding in patients with heterozygous factor XI deficiency.
    Guéguen P; Galinat H; Blouch MT; Bridey F; Duchemin J; Le Gal G; Abgrall JF; Pan-Petesch B
    Br J Haematol; 2012 Jan; 156(2):245-51. PubMed ID: 22098495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
    Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease.
    Gill JC; Shapiro A; Valentino LA; Bernstein J; Friedman C; Nichols WL; Manco-Johnson M
    Haemophilia; 2011 Nov; 17(6):895-905. PubMed ID: 21535320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause.
    Mehic D; Hofer S; Jungbauer C; Kaider A; Haslacher H; Eigenbauer E; Rejtő J; Schwartz D; Jilma B; Ay C; Pabinger I; Gebhart J
    Blood Adv; 2020 Oct; 4(20):5157-5164. PubMed ID: 33095871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating patients for bleeding disorders when most of the "usual" ones have been ruled out.
    Mehic D; Pabinger I; Gebhart J
    Res Pract Thromb Haemost; 2023 Nov; 7(8):102242. PubMed ID: 38193045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease.
    De Wee EM; Klaij K; Eikenboom HC; Van Der Bom JG; Fijnvandraat K; Laros-Van Gorkom BA; Mauser-Bunschoten EP; Meijer K; Goverde G; Van Der Linden PW; Rijken DC; Leebeek FW;
    Haemophilia; 2012 May; 18(3):444-51. PubMed ID: 21910790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discriminatory power of bleeding assessment tools in adult patients with a mild to moderate bleeding tendency.
    Gebhart J; Hofer S; Kaider A; Rejtö J; Ay C; Pabinger I
    Eur J Intern Med; 2020 Aug; 78():34-40. PubMed ID: 32317240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.